MACK – merrimack pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
4/30
05:15 pm
mack
Low
Merrimack Pharmaceuticals Announces Notification of Plan to Voluntary Delist Common Stock on NASDAQ Subject to Receipt of Stockholder Approval of Plan of Dissolution
3/27
04:50 pm
mack
Low
Merrimack Receives $225 Million Milestone Payment from Ipsen [Yahoo! Finance]
3/27
04:30 pm
mack
Low
Merrimack Receives $225 Million Milestone Payment from Ipsen
3/7
04:30 pm
mack
Low
Merrimack Reports Full Year 2023 Financial Results
3/4
07:17 am
mack
Low
Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) is definitely on the radar of hedge funds investors who own 35% of the company [Yahoo! Finance]
4/30
05:24 pm
mack
Low
Form DEFA14A MERRIMACK PHARMACEUTICAL
4/30
05:22 pm
mack
Low
Form 8-K MERRIMACK PHARMACEUTICAL For: Apr 30
4/1
04:29 pm
mack
Low
Form DEFR14A MERRIMACK PHARMACEUTICAL
3/27
05:00 pm
mack
Low
Form DEFA14A MERRIMACK PHARMACEUTICAL
3/27
04:58 pm
mack
Low
Form 8-K MERRIMACK PHARMACEUTICAL For: Mar 27
Show more
Top News Gainers
11/12 Q3/2019 9/30/2019 EPS -0.050 ZacksConsensus N/A ActVsEst N/A - N/A 11.0%
9/5 Merrimack Pharmaceuticals Announces Per Share Amount for Previously Declared Special Dividend 9.9%
12/3 Merrimack Receives $5 Million Milestone Payment from Ipsen; Declares $6.7 Million Special Dividend 9.9%
4/2 Merrimack Divests Early Stage Asset for $2.25 Million; Provides Strategy Update 8.6%
7/24 Form SC 13D/A MERRIMACK PHARMACEUTICAL Filed by: JFL Capital Management, LLC 7.6%
7/26 Form 8-K MERRIMACK PHARMACEUTICAL For: Jul 24 5.8%
8/5 Form PREC14A MERRIMACK PHARMACEUTICAL Filed by: MERRIMACK PHARMACEUTICALS INC 5.5%
9/20 Form PRER14A MERRIMACK PHARMACEUTICAL 4.3%
7/25 Form 3 MERRIMACK PHARMACEUTICAL For: Jul 24 Filed by: 22NW GP, Inc. 4.1%
4/22 Form DEF 14A MERRIMACK PHARMACEUTICAL For: May 28 4.1%
Top News Decliners
12/12 Merrimack Pharmaceuticals Inc (NASDAQ: MACK) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -14.8%
9/26 Form DEF 14A MERRIMACK PHARMACEUTICAL For: Oct 17 -9.7%
5/30 Merrimack Pharmaceuticals Announces Completion of Strategic Review, Preservation of Ipsen Milestones and Special Cash Dividend -6.1%
9/24 JFL Capital Ends Campaign at Merrimack -5.3%
11/19 Form SC 13D/A MERRIMACK PHARMACEUTICAL Filed by: JFL Capital Management, LLC -5.3%
4/7 Form 4 MERRIMACK PHARMACEUTICAL For: Apr 03 Filed by: Western Standard LLC -5.3%
3/13 Form S-8 MERRIMACK PHARMACEUTICAL -4.8%
7/1 Form 8-K MERRIMACK PHARMACEUTICAL For: Jun 25 -3.5%
4/8 Form 4 MERRIMACK PHARMACEUTICAL For: Apr 07 Filed by: Newtyn Management, LLC -2.8%
8/26 Merrimack Pharmaceuticals Issues Letter to Shareholders -2.7%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3